Actinium Pharmaceuticals, Inc. (ATNM)

$1.75 -5.91% $-0.11 Healthcare

Actinium Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing therapies for bone marrow transplant (BMT) or a type of cellular therapy, and for other adoptive cell therapies. Its lead product candidate, I-131 apamistamab (Iomab-B) that is in a pivotal Phase III clinical trial for elderly relapsed or refractory acute myeloid leukemia trial for BMT conditioning; and a Phase I study with a CD19- targeted CAR T-cell therapy with memorial sloan kettering cancer center. The company also offers clinical and preclinical development programs that utilize multiple isotopes, including Actinium-225, Iodine-131, and Lutetium-177 directed at multiple validated cancer targets, including CD45, CD33, CD38, CD47, HER2, and HER3 for targeted conditioning prior to cell and gene therapies, such as bone marrow transplant and cancer therapeutics as single agents or in combination with other therapeutic modalities. It has collaboration with Astellas Pharma, Inc. to develop theranostics for solid tumor indications; EpicentRx, Inc that focuses on a novel CD47 immunotherapy targeted radiotherapy; and AVEO Oncology that focuses on developing a HER3 targeting ARC for solid tumors. The company was incorporated in 2000 and is based in New York, New York.

$54.52M

Mr. Sandesh C. Seth M.B.A., M.S., MBA

32.00

New York, NY

Mar 26, 2014

-1.16

$-1.51

8.84

8.95

-52,620.99%

-1.31

-0.03

1.28

715.40

8.95

-47.43%

-101.69%

Similar stocks (19)

Exelixis, Inc.

EXEL

$27.47 3.82%
Uptrend

Viking Therapeutics, Inc.

VKTX

$67.10 0.55%
Uptrend

Madrigal Pharmaceuticals, Inc.

MDGL

$233.39 -3.48%
Downtrend

Axsome Therapeutics, Inc.

AXSM

$92.41 -1.35%
Uptrend

TG Therapeutics, Inc.

TGTX

$24.89 4.89%
Uptrend

Cassava Sciences, Inc.

SAVA

$28.34 0.78%
Neutral

Rigel Pharmaceuticals, Inc.

RIGL

$13.75 0.36%
Neutral

Sangamo Therapeutics, Inc.

SGMO

$0.84 -1.10%
Uptrend

Seres Therapeutics, Inc.

MCRB

$1.02 2.08%
Downtrend

Kodiak Sciences Inc.

KOD

$2.68 -1.11%
Downtrend

Annovis Bio, Inc.

ANVS

$8.00 -0.12%
Downtrend

Fortress Biotech, Inc.

FBIO

$1.94 -1.52%
Downtrend

Eyenovia, Inc.

EYEN

$0.53 -0.45%
Downtrend

Reviva Pharmaceuticals Holdings, Inc.

RVPH

$1.17 -2.50%
Downtrend

Ocuphire Pharma, Inc.

OCUP

$1.30 0.00%
Downtrend

MiNK Therapeutics, Inc.

INKT

$0.75 -3.03%
Downtrend

BioXcel Therapeutics, Inc.

BTAI

$0.64 -5.88%
Downtrend

Cognition Therapeutics, Inc.

CGTX

$0.60 -0.85%
Downtrend

TransCode Therapeutics, Inc.

RNAZ

$0.26 0.50%
Downtrend

ETF Exposure (20)

Vanguard Russell 2000 Growth Index Fund

VTWG

0.02%

$202.06 0.06%
Neutral

iShares Micro-Cap ETF

IWC

0.01391%

$122.64 -0.28%
Uptrend

Vanguard Russell 2000 Index Fund

VTWO

0.01%

$88.01 0.39%
Neutral

iShares Russell 2000 Growth ETF

IWO

0.00407%

$277.57 0.12%
Uptrend

iShares Russell 2000 ETF

IWM

0.00203%

$217.67 0.39%
Uptrend

ProShares Ultra Russell2000

UWM

7.65579673346695e-4%

$41.65 0.77%
Neutral

ProShares UltraPro Russell2000

URTY

3.7730389414046463e-4%

$49.88 1.11%
Neutral

ProShares Hedge Replication ETF

HDG

3.211182036682154e-4%

$49.80 0.13%
Uptrend

Dimensional U.S. Small Cap ETF

DFAS

1.8646e-4%

$63.47 0.53%
Uptrend

Vanguard Balanced Index Fund Institutional Shares

VBAIX

0%

$49.45 0.51%
Uptrend

Vanguard Balanced Index Fund Admiral Shares

VBIAX

0%

$49.44 0.51%
Uptrend

Vanguard Balanced Index Fund

VBINX

0%

$49.44 0.51%
Uptrend

Vanguard Extended Market Index Fund Institutional Shares

VIEIX

0%

$134.52 1.86%
Uptrend

Vanguard Institutional Total Stock Market Index Fund Institutional Shares

VITNX

0%

$96.10 0.71%
Uptrend

Vanguard Institutional Total Stock Market Index Fund

VITPX

0%

$96.07 0.71%
Uptrend

Vanguard Total Stock Market Index Fund

VITSX

0%

$134.94 0.72%
Uptrend

Vanguard Russell 3000 Index Fund

VTHR

0%

$249.12 0.18%
Uptrend

Vanguard Total Stock Market Index Fund

VTI

0%

$277.72 0.18%
Uptrend

Vanguard Total Stock Market Index Fund

VTSAX

0%

$134.92 0.72%
Uptrend

Vanguard Extended Market Index Fund

VXF

0%

$178.36 0.55%
Uptrend